Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Name: Work Video:
Duration: 3 min 30 s
Pasi A. Jänne; Frédéric Bigot; Kyriakos P. Papadopoulos; Lauriane Eberst; David Sommerhalder; Loïc Lebellec; Pei Jye Voon; Bruna Pellini; Ewa Kalinka‐Warzocha; Kathryn C. Arbour; Benjamin Herzberg; Valentina Boni; Stéphanie Bordenave-Juchereau; Hyun Woo Lee; Sai I. Ou; Jonathan W. Riess; J. Thaddeus Beck; Mariano Ponz‐Sarvisé; Paolo A. Ascierto; Yoon Ji Choi; Michelle Yang; Lei Bao; Rakesh Raman; Luxi Yang; Yunming Mu; Sofia Wong; Richa Dua; Melissa L. Johnson
{'id': 'https://openalex.org/W4389227351', 'doi': 'https://doi.org/10.1158/1535-7163.targ-23-pr014', 'title': 'Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment', 'display_name': 'Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment', 'publication_year': 2023, 'publication_date': '2023-12-01', 'ids': {'openalex': 'https://openalex.org/W4389227351', 'doi': 'https://doi.org/10.1158/1535-7163.targ-23-pr014'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-23-pr014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5048675362', 'display_name': 'Pasi A. Jänne', 'orcid': 'https://orcid.org/0000-0002-7821-4928'}, 'institutions': [{'id': 'https://openalex.org/I4210117453', 'display_name': 'Dana-Farber Cancer Institute', 'ror': 'https://ror.org/02jzgtq86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210117453']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Pasi A. Jänne', 'raw_affiliation_strings': ['1Dana Farber Cancer Institute, Boston, MA,'], 'affiliations': [{'raw_affiliation_string': '1Dana Farber Cancer Institute, Boston, MA,', 'institution_ids': ['https://openalex.org/I4210117453']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077165339', 'display_name': 'Frédéric Bigot', 'orcid': 'https://orcid.org/0000-0001-5890-107X'}, 'institutions': [{'id': 'https://openalex.org/I4210106090', 'display_name': "Institut de Cancérologie de l'Ouest", 'ror': 'https://ror.org/01m6as704', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210106090']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Frédéric Bigot', 'raw_affiliation_strings': ['2Institut de cancérologie de l’Ouest Angers, Angers, France,'], 'affiliations': [{'raw_affiliation_string': '2Institut de cancérologie de l’Ouest Angers, Angers, France,', 'institution_ids': ['https://openalex.org/I4210106090']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022467575', 'display_name': 'Kyriakos P. Papadopoulos', 'orcid': 'https://orcid.org/0000-0002-0667-2620'}, 'institutions': [{'id': 'https://openalex.org/I4210119066', 'display_name': 'South Texas Accelerated Research Therapeutics', 'ror': 'https://ror.org/01scs7915', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210119066']}, {'id': 'https://openalex.org/I4210100270', 'display_name': 'Clinical Trials of Texas', 'ror': 'https://ror.org/017vjfp21', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210100270']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kyriakos Papadopoulos', 'raw_affiliation_strings': ['3START, San Antonio, TX,'], 'affiliations': [{'raw_affiliation_string': '3START, San Antonio, TX,', 'institution_ids': ['https://openalex.org/I4210119066', 'https://openalex.org/I4210100270']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090555713', 'display_name': 'Lauriane Eberst', 'orcid': 'https://orcid.org/0000-0003-0973-5954'}, 'institutions': [{'id': 'https://openalex.org/I4210090340', 'display_name': 'Institut de Cancérologie Strasbourg', 'ror': 'https://ror.org/008fdbn61', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210090340']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Lauriane Eberst', 'raw_affiliation_strings': ['4ICANS-Institut de Cancérologie de Strasbourg Europe, Strasbourg, France,'], 'affiliations': [{'raw_affiliation_string': '4ICANS-Institut de Cancérologie de Strasbourg Europe, Strasbourg, France,', 'institution_ids': ['https://openalex.org/I4210090340']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063897579', 'display_name': 'David Sommerhalder', 'orcid': 'https://orcid.org/0000-0002-7033-9064'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'David Sommerhalder', 'raw_affiliation_strings': ['5NEXT Oncology TM, San Antonio, TX,'], 'affiliations': [{'raw_affiliation_string': '5NEXT Oncology TM, San Antonio, TX,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004551731', 'display_name': 'Loïc Lebellec', 'orcid': 'https://orcid.org/0000-0002-6079-0185'}, 'institutions': [{'id': 'https://openalex.org/I4210131356', 'display_name': 'Centre Oscar Lambret', 'ror': 'https://ror.org/03xfq7a50', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210131356', 'https://openalex.org/I4210141925']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Loic Lebellec', 'raw_affiliation_strings': ['6Centre Oscar Lambret, Lille, France,'], 'affiliations': [{'raw_affiliation_string': '6Centre Oscar Lambret, Lille, France,', 'institution_ids': ['https://openalex.org/I4210131356']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113685503', 'display_name': 'Pei Jye Voon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800797430', 'display_name': 'Sarawak General Hospital', 'ror': 'https://ror.org/01y946378', 'country_code': 'MY', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800797430']}], 'countries': ['MY'], 'is_corresponding': False, 'raw_author_name': 'Pei Jye Voon', 'raw_affiliation_strings': ['7Hospital Umum Sarawak, Kuching, Malaysia,'], 'affiliations': [{'raw_affiliation_string': '7Hospital Umum Sarawak, Kuching, Malaysia,', 'institution_ids': ['https://openalex.org/I2800797430']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082491082', 'display_name': 'Bruna Pellini', 'orcid': 'https://orcid.org/0000-0003-0898-0202'}, 'institutions': [{'id': 'https://openalex.org/I3019308854', 'display_name': 'Moffitt Cancer Center', 'ror': 'https://ror.org/01xf75524', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019308854']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bruna Pellini', 'raw_affiliation_strings': ['8Moffitt Cancer Center & Research Institute, Tampa, FL,'], 'affiliations': [{'raw_affiliation_string': '8Moffitt Cancer Center & Research Institute, Tampa, FL,', 'institution_ids': ['https://openalex.org/I3019308854']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073907665', 'display_name': 'Ewa Kalinka‐Warzocha', 'orcid': 'https://orcid.org/0000-0003-4791-8372'}, 'institutions': [{'id': 'https://openalex.org/I4210143919', 'display_name': 'Polish Mother’s Memorial Hospital Research Institute', 'ror': 'https://ror.org/059ex7y15', 'country_code': 'PL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210143919']}], 'countries': ['PL'], 'is_corresponding': False, 'raw_author_name': 'Ewa Kalinka', 'raw_affiliation_strings': ['9Instytut Centrum Zdrowia Matki Polki, Lodz, Poland,'], 'affiliations': [{'raw_affiliation_string': '9Instytut Centrum Zdrowia Matki Polki, Lodz, Poland,', 'institution_ids': ['https://openalex.org/I4210143919']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047053195', 'display_name': 'Kathryn C. Arbour', 'orcid': 'https://orcid.org/0000-0001-5951-8427'}, 'institutions': [{'id': 'https://openalex.org/I39965400', 'display_name': 'Kettering University', 'ror': 'https://ror.org/03rcspa57', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39965400']}, {'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathryn Arbour', 'raw_affiliation_strings': ['10Memorial Sloan Kettering Cancer Center, New York, NY,'], 'affiliations': [{'raw_affiliation_string': '10Memorial Sloan Kettering Cancer Center, New York, NY,', 'institution_ids': ['https://openalex.org/I39965400', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020788550', 'display_name': 'Benjamin Herzberg', 'orcid': 'https://orcid.org/0000-0002-3253-3106'}, 'institutions': [{'id': 'https://openalex.org/I2799503643', 'display_name': 'Columbia University Irving Medical Center', 'ror': 'https://ror.org/01esghr10', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799503643']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Benjamin Herzberg', 'raw_affiliation_strings': ['11Columbia University Irving Medical Center, New York, NY,'], 'affiliations': [{'raw_affiliation_string': '11Columbia University Irving Medical Center, New York, NY,', 'institution_ids': ['https://openalex.org/I2799503643']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020352800', 'display_name': 'Valentina Boni', 'orcid': 'https://orcid.org/0000-0002-8675-0018'}, 'institutions': [{'id': 'https://openalex.org/I4210109886', 'display_name': 'Hospital Universitario Quirónsalud Madrid', 'ror': 'https://ror.org/018q88z15', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210109886']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Valentina Boni', 'raw_affiliation_strings': ['12NEXT Madrid-Universitary Hospital QuironSalud, Madrid, Spain,'], 'affiliations': [{'raw_affiliation_string': '12NEXT Madrid-Universitary Hospital QuironSalud, Madrid, Spain,', 'institution_ids': ['https://openalex.org/I4210109886']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061400266', 'display_name': 'Stéphanie Bordenave-Juchereau', 'orcid': 'https://orcid.org/0000-0001-9735-5112'}, 'institutions': [{'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Stephanie Bordenave', 'raw_affiliation_strings': ['13Centre Hospitalier Universitaire de Nantes, Nantes, France,'], 'affiliations': [{'raw_affiliation_string': '13Centre Hospitalier Universitaire de Nantes, Nantes, France,', 'institution_ids': ['https://openalex.org/I3019204325']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100607088', 'display_name': 'Hyun Woo Lee', 'orcid': 'https://orcid.org/0000-0002-6879-9686'}, 'institutions': [{'id': 'https://openalex.org/I4210103252', 'display_name': 'Ajou University Hospital', 'ror': 'https://ror.org/01bzpky79', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210103252']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Hyun Woo Lee', 'raw_affiliation_strings': ['14The Ajou University Hospital, Suwon, Korea, Republic of,'], 'affiliations': [{'raw_affiliation_string': '14The Ajou University Hospital, Suwon, Korea, Republic of,', 'institution_ids': ['https://openalex.org/I4210103252']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104206376', 'display_name': 'Sai I. Ou', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I204250578', 'display_name': 'University of California, Irvine', 'ror': 'https://ror.org/04gyf1771', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I204250578']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sai I. Ou', 'raw_affiliation_strings': ['15University of California Irvine, Irvine, CA,'], 'affiliations': [{'raw_affiliation_string': '15University of California Irvine, Irvine, CA,', 'institution_ids': ['https://openalex.org/I204250578']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082506495', 'display_name': 'Jonathan W. Riess', 'orcid': 'https://orcid.org/0000-0001-7370-7304'}, 'institutions': [{'id': 'https://openalex.org/I4390039352', 'display_name': 'UC Davis Comprehensive Cancer Center', 'ror': 'https://ror.org/02kcc1z29', 'country_code': None, 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210160856', 'https://openalex.org/I4390039352']}, {'id': 'https://openalex.org/I84218800', 'display_name': 'University of California, Davis', 'ror': 'https://ror.org/05rrcem69', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I84218800']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jonathan Wesley Riess', 'raw_affiliation_strings': ['16University of California Davis Comprehensive Cancer Center, Davis, CA,'], 'affiliations': [{'raw_affiliation_string': '16University of California Davis Comprehensive Cancer Center, Davis, CA,', 'institution_ids': ['https://openalex.org/I4390039352', 'https://openalex.org/I84218800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003887338', 'display_name': 'J. Thaddeus Beck', 'orcid': 'https://orcid.org/0000-0002-3341-9903'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Joseph T. Beck', 'raw_affiliation_strings': ['17Highlands Oncology, Springdale, AR,'], 'affiliations': [{'raw_affiliation_string': '17Highlands Oncology, Springdale, AR,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028783464', 'display_name': 'Mariano Ponz‐Sarvisé', 'orcid': 'https://orcid.org/0000-0002-3240-729X'}, 'institutions': [{'id': 'https://openalex.org/I4210135003', 'display_name': 'Clinica Universidad de Navarra', 'ror': 'https://ror.org/03phm3r45', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210135003']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Mariano Ponz-Sarvise', 'raw_affiliation_strings': ['18Cancer Center Clinica Universidad de Navarra, Pamplona, Spain,'], 'affiliations': [{'raw_affiliation_string': '18Cancer Center Clinica Universidad de Navarra, Pamplona, Spain,', 'institution_ids': ['https://openalex.org/I4210135003']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029398339', 'display_name': 'Paolo A. Ascierto', 'orcid': 'https://orcid.org/0000-0002-8322-475X'}, 'institutions': [{'id': 'https://openalex.org/I4210141868', 'display_name': 'Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"', 'ror': 'https://ror.org/0506y2b23', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210141868', 'https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Paolo Antonio Ascierto', 'raw_affiliation_strings': ['19Istituto Nazionale Tumori IRCCS G. Pascale, Napoli, Italy,'], 'affiliations': [{'raw_affiliation_string': '19Istituto Nazionale Tumori IRCCS G. Pascale, Napoli, Italy,', 'institution_ids': ['https://openalex.org/I4210141868']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035331177', 'display_name': 'Yoon Ji Choi', 'orcid': 'https://orcid.org/0000-0002-1831-0555'}, 'institutions': [{'id': 'https://openalex.org/I2799980853', 'display_name': 'Korea University Medical Center', 'ror': 'https://ror.org/02cs2sd33', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799980853']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Yoon Ji Choi', 'raw_affiliation_strings': ['20Korea University Anam Hospital, Seoul, Korea, Republic of,'], 'affiliations': [{'raw_affiliation_string': '20Korea University Anam Hospital, Seoul, Korea, Republic of,', 'institution_ids': ['https://openalex.org/I2799980853']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063897711', 'display_name': 'Michelle Yang', 'orcid': 'https://orcid.org/0000-0002-6193-7142'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michelle Yang', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015836290', 'display_name': 'Lei Bao', 'orcid': 'https://orcid.org/0000-0002-0248-8367'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lei Bao', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075069119', 'display_name': 'Rakesh Raman', 'orcid': 'https://orcid.org/0000-0003-0159-7227'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rakesh Raman', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035854930', 'display_name': 'Luxi Yang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Luxi Yang', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112876325', 'display_name': 'Yunming Mu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yunming Mu', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103591979', 'display_name': 'Sofia Wong', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sofia Wong', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039253772', 'display_name': 'Richa Dua', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richa Dua', 'raw_affiliation_strings': ['21Revolution Medicines, Inc., Redwood City, CA,'], 'affiliations': [{'raw_affiliation_string': '21Revolution Medicines, Inc., Redwood City, CA,', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049294543', 'display_name': 'Melissa L. Johnson', 'orcid': 'https://orcid.org/0000-0001-9874-1314'}, 'institutions': [{'id': 'https://openalex.org/I4210135086', 'display_name': 'Tennessee Oncology', 'ror': 'https://ror.org/03754ky26', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210135086']}, {'id': 'https://openalex.org/I4210100810', 'display_name': 'Sarah Cannon', 'ror': 'https://ror.org/014t21j89', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210100810']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Melissa Johnson', 'raw_affiliation_strings': ['22Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN.'], 'affiliations': [{'raw_affiliation_string': '22Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN.', 'institution_ids': ['https://openalex.org/I4210135086', 'https://openalex.org/I4210100810']}]}], 'institution_assertions': [], 'countries_distinct_count': 7, 'institutions_distinct_count': 24, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 4.165, 'has_fulltext': False, 'cited_by_count': 18, 'citation_normalized_percentile': {'value': 0.99998, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '22', 'issue': '12_Supplement', 'first_page': 'PR014', 'last_page': 'PR014'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9935, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9935, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13526', 'display_name': '14-3-3 protein interactions', 'score': 0.9927, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12827', 'display_name': 'Biochemical and Molecular Research', 'score': 0.9886, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6469871}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5341761}, {'id': 'https://openalex.org/C2780580376', 'wikidata': 'https://www.wikidata.org/wiki/Q186889', 'display_name': 'Nausea', 'level': 2, 'score': 0.5292399}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.51270616}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.46320924}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.42872617}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.41767016}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3607617}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.32074732}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-23-pr014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.81}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2567358723', 'https://openalex.org/W230338489', 'https://openalex.org/W2110192055', 'https://openalex.org/W2099575842', 'https://openalex.org/W2073177056', 'https://openalex.org/W2046280088', 'https://openalex.org/W2044251933', 'https://openalex.org/W2027491976', 'https://openalex.org/W154520217', 'https://openalex.org/W1505739641'], 'abstract_inverted_index': {'Abstract': [0], 'Background': [1], 'RMC-6291': [2, 31, 193, 396], 'is': [3, 434], 'a': [4, 13, 33, 198, 307, 319, 326, 509], 'potent,': [5], 'covalent,': [6], 'orally': [7], 'bioavailable': [8], 'KRASG12C(ON)': [9, 62, 76, 512], 'inhibitor': [10, 371, 384, 404, 413, 521], 'that': [11, 148, 329], 'uses': [12], 'novel': [14], 'tri-complex': [15, 511], 'mechanism': [16], 'to': [17, 45, 70, 89, 142, 153, 287, 331, 382, 411], 'selectively': [18], 'target': [19, 213], 'the': [20, 25, 46, 422, 527], 'active,': [21], 'GTP-bound': [22], 'state': [23], 'of': [24, 42, 61, 107, 161, 165, 186, 201, 207, 215, 229, 270, 282, 395, 507, 526], 'oncogenic': [26], 'KRASG12C.': [27], 'In': [28], 'preclinical': [29], 'models,': [30], 'achieved': [32], 'superior': [34], 'response': [35, 43, 357], 'rate,': [36], 'deeper': [37], 'regressions': [38], 'and': [39, 58, 85, 113, 118, 122, 158, 178, 204, 220, 240, 296, 302, 342, 373, 406, 504, 535], 'longer': [40], 'duration': [41], 'compared': [44], 'KRASG12C(OFF)': [47, 71, 370, 383, 403, 412, 520], 'inhibitor,': [48, 513], 'adagrasib.': [49], 'Receptor': [50], 'tyrosine': [51], 'kinase': [52], '(RTK)': [53], 'overexpression': [54], 'and/or': [55, 294], 'hyperactivating': [56], 'alterations': [57], 'new': [59], 'synthesis': [60], 'have': [63], 'been': [64], 'identified': [65], 'as': [66], 'potential': [67, 423], 'resistance': [68], 'mechanisms': [69], 'inhibitors.': [72], 'Preclinical': [73], 'modeling': [74], 'shows': [75, 391], 'inhibitors': [77], 'retain': [78], 'potency': [79], 'in': [80, 227, 253, 338, 364, 378, 397, 407, 514], 'cells': [81], 'with': [82, 97, 132, 171, 197, 367, 400, 426, 516], 'RTK': [83], 'activation': [84], 'further': [86, 154], 'are': [87], 'expected': [88], 'rapidly': [90], 'extinguish': [91], 'newly': [92], 'synthesized': [93], 'KRASG12C(ON).': [94], 'Methods': [95], 'Patients': [96], 'previously': [98], 'treated,': [99, 177], 'advanced': [100], 'KRASG12C-mutated': [101, 398, 408], 'solid': [102, 174], 'tumors': [103, 175], 'received': [104], 'escalating': [105], 'doses': [106], 'RMC-6291.': [108, 162], 'Doses': [109], 'included': [110, 343], '50,': [111], '100,': [112, 119], '200mg': [114, 265], 'once': [115], 'daily': [116, 125], '(QD)': [117], '200,': [120], '300,': [121], '400mg': [123, 258, 419], 'twice': [124], '(BID).': [126], 'Each': [127], 'cycle': [128], 'had': [129, 274], '21': [130], 'days,': [131], 'efficacy': [133], 'assessed': [134], 'every': [135], '6': [136], 'weeks.': [137], 'Additional': [138], 'patients': [139, 170, 230, 255, 273, 299, 317, 344, 366, 380, 515], 'were': [140, 176, 231, 249, 300], 'enrolled': [141, 345], 'backfill': [143], 'cohorts': [144], 'at': [145, 217, 257, 261, 264, 306], 'dose': [146, 292, 353], 'levels': [147], 'cleared': [149], 'dose-limiting': [150], 'toxicity': [151], 'evaluation': [152], 'characterize': [155], 'PK,': [156], 'safety,': [157], 'anti-tumor': [159, 393, 505], 'activity': [160, 394, 506], 'Results': [163], 'As': [164], 'August': [166], '8,': [167], '2023,': [168], '47': [169], 'KRASG12C': [172], 'mutated': [173], '35': [179], 'remained': [180, 303], 'on': [181, 304, 532], 'treatment.': [182, 385, 414], 'The': [183, 244, 355], 'median': [184, 199], 'number': [185], 'prior': [187, 369, 402, 519], 'therapies': [188], 'was': [189, 314, 336, 359, 416], '3': [190, 362, 376], '(range,': [191], '1-7).': [192], 'exhibited': [194], 'dose-dependent': [195], 'exposure': [196], 'Tmax': [200], '1.0': [202], 'hour': [203], 'terminal': [205], 'half-life': [206], '1.8': [208], 'hours.': [209], 'Modeling': [210], 'projected': [211], 'average': [212, 276], 'occupancy': [214], '≥~90%': [216], '100mg': [218], 'BID': [219], 'above.': [221], 'Treatment-related': [222], 'adverse': [223], 'events': [224, 281], '(TRAEs)': [225], 'occurring': [226], '≥10%': [228], 'nausea': [232], '(34%),': [233], 'diarrhea': [234], '(30%),': [235], 'QTc': [236, 250, 277, 284], 'prolongation': [237, 251, 285], '(21%),': [238], 'vomiting': [239], 'fatigue': [241], '(15%': [242], 'each).': [243], 'most': [245], 'common': [246], 'Gr3': [247, 283], 'TRAEs': [248], 'reported': [252], '5': [254, 272, 298, 323], '(3': [256], 'BID,': [259, 420], '1': [260, 263], '300mg,': [262], 'BID).': [266], 'Only': [267], 'one': [268], 'out': [269], 'these': [271], 'an': [275], 'interval': [278], '&amp;gt;501ms.': [279], 'Most': [280], 'resolved': [286], 'Gr1': [288], 'or': [289, 322, 325, 517], 'normal': [290], 'following': [291], 'interruption': [293], 'reduction,': [295], 'all': [297, 352], 'asymptomatic': [301], 'treatment': [305, 332, 522], 'reduced': [308], 'dose.': [309], 'No': [310, 316], 'treatment-related': [311, 320], '≥Gr3': [312], 'hepatotoxicity': [313], 'observed.': [315], 'experienced': [318], 'Gr4': [321], 'AE,': [324], 'treatment-emergent': [327], 'AE': [328], 'led': [330], 'discontinuation.': [333], 'Efficacy': [334], 'analysis': [335], 'conducted': [337], 'two': [339], 'dominant': [340], 'subgroups': [341], '≥8': [346], 'weeks': [347], 'before': [348], 'data': [349, 389], 'cutoff': [350], 'across': [351], 'levels.': [354], 'objective': [356], 'rate': [358], '57%': [360], '(4/7;': [361], 'confirmed)': [363, 377], 'NSCLC': [365, 399], 'recent': [368, 401], 'treatment,': [372, 405], '44%': [374], '(4/9;': [375], 'CRC': [379, 409], 'naive': [381, 410], 'Conclusions': [386], 'This': [387], 'preliminary': [388], 'set': [390], 'promising': [392], 'Tolerability': [415], 'acceptable': [417], 'below': [418], 'suggesting': [421], 'for': [424], 'combination': [425], 'standard': [427], 'therapy,': [428], 'including': [429], 'immunologic': [430], 'agents.': [431], 'Dose': [432], 'optimization': [433], 'ongoing.': [435], 'Citation': [436], 'Format:': [437], 'Pasi': [438], 'A.': [439], 'Jänne,': [440], 'Frédéric': [441], 'Bigot,': [442], 'Kyriakos': [443], 'Papadopoulos,': [444], 'Lauriane': [445], 'Eberst,': [446], 'David': [447], 'Sommerhalder,': [448], 'Loic': [449], 'Lebellec,': [450], 'Pei': [451], 'Jye': [452], 'Voon,': [453], 'Bruna': [454], 'Pellini,': [455], 'Ewa': [456], 'Kalinka,': [457], 'Kathryn': [458], 'Arbour,': [459], 'Benjamin': [460], 'Herzberg,': [461], 'Valentina': [462], 'Boni,': [463], 'Stephanie': [464], 'Bordenave,': [465], 'Hyun': [466], 'Woo': [467], 'Lee,': [468], 'Sai': [469], 'I.': [470], 'Ou,': [471], 'Jonathan': [472], 'Wesley': [473], 'Riess,': [474], 'Joseph': [475], 'T.': [476], 'Beck,': [477], 'Mariano': [478], 'Ponz-Sarvise,': [479], 'Paolo': [480], 'Antonio': [481], 'Ascierto,': [482], 'Yoon': [483], 'Ji': [484], 'Choi,': [485], 'Michelle': [486], 'Yang,': [487, 493], 'Lei': [488], 'Bao,': [489], 'Rakesh': [490], 'Raman,': [491], 'Luxi': [492], 'Yunming': [494], 'Mu,': [495], 'Sofia': [496], 'Wong,': [497], 'Richa': [498], 'Dua,': [499], 'Melissa': [500], 'Johnson.': [501], 'Preliminary': [502], 'safety': [503], 'RMC-6291,': [508], 'first-in-class,': [510], 'without': [518], '[abstract].': [523], 'In:': [524], 'Proceedings': [525], 'AACR-NCI-EORTC': [528], 'Virtual': [529], 'International': [530], 'Conference': [531], 'Molecular': [533], 'Targets': [534], 'Cancer': [536, 547], 'Therapeutics;': [537], '2023': [538], 'Oct': [539], '11-15;': [540], 'Boston,': [541], 'MA.': [542], 'Philadelphia': [543], '(PA):': [544], 'AACR;': [545], 'Mol': [546], 'Ther': [548], '2023;22(12': [549], 'Suppl):Abstract': [550], 'nr': [551], 'PR014.': [552]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4389227351', 'counts_by_year': [{'year': 2024, 'cited_by_count': 17}, {'year': 2023, 'cited_by_count': 1}], 'updated_date': '2025-01-13T03:07:45.736713', 'created_date': '2023-12-02'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
